Keyphrases
Estrogen Receptor
100%
Transcriptional Activation
100%
Hormone Binding
100%
Mammalian System
100%
Yeast System
100%
Estrogen
45%
Antiestrogen
36%
Ligand-binding Domain
36%
Aziridine
27%
Cysteine
18%
Site-directed mutagenesis
18%
Breast Cancer
18%
Chemical mutagenesis
18%
Ligand Discrimination
18%
Affinity Labeling
18%
Amino Acids
9%
3D Structure
9%
Receptor-interacting Protein Kinase 1 (RIPK1)
9%
Labeling Experiment
9%
Breast Cancer Cells
9%
Binding Pocket
9%
Mechanism of Action
9%
Membrane Estrogen Receptor
9%
Dominant Negative
9%
Carboxyl Terminus
9%
Substantial Evidence
9%
Binding Ligand
9%
Bioactivity
9%
Hormone-dependent
9%
Ligand Binding
9%
Estrogen Therapy
9%
Activation Function
9%
Endocrine Therapy
9%
Linear Sequence
9%
Receptor-ligand Binding
9%
Estrogen Receptor Ligands
9%
Receptor Mechanisms
9%
Biochemistry, Genetics and Molecular Biology
Estrogen Receptor
100%
Transcription Initiation
100%
Hormone Binding
100%
Binding Domain
30%
Wild Type
23%
Ligand Binding
23%
Cysteine
15%
Site-Directed Mutagenesis
15%
Affinity Label
15%
Chemical Mutagenesis
15%
Amino Acids
7%
C-Terminus
7%
Agonist
7%
Cancer Cell
7%
Biological Activity
7%
Neuroscience
Estrogen Receptor
100%
Hormone Binding
100%
Transcription Initiation
100%
Antiestrogen
38%
Cysteine
15%
Tamoxifen
15%
Ligand Binding
15%
Site-Directed Mutagenesis
15%
Mutagenesis
15%
Agonist
7%
Amino Acid
7%
Epileptic Absence
7%
C-Terminus
7%
1 Aziridino 6,7 Bis(4 Hydroxyphenyl) 5 Nonanone
7%
Hormone Therapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Antiestrogen
38%
Breast Cancer
23%
Cysteine
15%
Mutagenesis
15%
Site-Directed Mutagenesis
15%
Tamoxifen Aziridine
15%
Epileptic Absence
7%
Amino Acid
7%
Endocrine Therapy
7%
1 Aziridino 6,7 Bis(4 Hydroxyphenyl) 5 Nonanone
7%